Cancer rates on the rise for millennials and Gen X
The “good old days” conjure up memories, often distorted of yesteryears of lower prices and a slower pace of living. Now they recall the time when young adults faced a lower risk of cancer.
A recent study by the American Cancer Society identified 17 different types of cancer, including breast, colon, rectal, pancreatic and uterine cancers, that are more likely to plague millennials and Generation X than they did their parents and grandparents.
Analyzing health data from over 20 million cancer patients in the U.S. for nearly two decades, the study showed common cancers are now occurring at two to three times the rate in millennials compared to baby boomers at the same age.
Though causes remain unknown, researchers believe several factors may contribute to this increase, including rising obesity rates, diets high in saturated fats and ultra-processed foods and environmental exposures to pollutants and carcinogens. Lifestyle changes − including video gaming and cell phone addictions − leading to more sedentary behavior and poor sleep habits also are thought to be contributing factors.
Despite a rise in common cancers, cervical cancer is on the decline. Human papillomavirus (HPV), frequently transmitted by sexual partners who show no signs or symptoms, causes more than 90 percent of cervical cancer cases. However, the HPV vaccine has played a significant role in reducing the numbers.
In addition to lifestyle changes, regular screenings such as mammograms, colonoscopies and Pap smears remain the best tactic to reverse current trends. Additionally, Providence provides Multi-Cancer Early Detection (MCED) testing, a comprehensive blood test that can detect cancer signals from more than 50 different types of cancer.
Contact a Providence physician today to determine which early detection screenings you qualify for and to learn more about MCED testing.
Cancers on the rise for millennials and Gen Xers include:
- Gastric cardia
- Small intestine
- Breast cancer that is estrogen receptor-positive
- Ovarian
- Liver (in women)
- Non-HPV-associated oral and pharynx cancers (in women)
- Anal (in men)
- Colorectal
- Uterine
- Gallbladder
- Kidney
- Pancreatic
- Myeloma
- Non-cardia gastric
- Testicular
- Leukemia
- Kaposi sarcoma (in men)